Type 2 & other diabetes

Efficacy and safety of once‐weekly insulins in type 2 diabetes: A systematic review and meta‐analysis

Diabetes Obes MetabPublished Systematic review and meta-analysis of randomised trials

Pooled result · HbA1c reductionResult — go to the resultPooled mean difference −0.12 % 95% CI −0.19 to −0.04

Authors' conclusion

OW insulins modestly improve glycaemic control without increasing hypoglycaemia risk, though slight weight gain may occur.

Study context

Population
Randomized Controlled Trials (RCTs) of Once-weekly (OW) insulins in T2D; PubMed, WoS, ClinicalTrials.gov and EU Clinical Trials searched up to June 202516 RCTs
Comparison
Once-weekly insulins vs once-daily insulin or semaglutide
Outcome
Efficacy (HbA1c, fasting plasma glucose (FPG), time-in-range (TIR), time-above-range) and safety outcomes (body weight, hypoglycaemia, time-below-range)
Methodological detailsfrequentist and Bayesian approaches, meta-regression
  • Frequentist and Bayesian approaches
  • Meta-regression

Pooled result

HbA1c reduction

Pooled mean difference

−0.12 %

95% CI −0.19 to −0.04

P = 0.007

OW insulinsvs Once-daily insulin or semaglutide
pooled mean difference −0.12 % (95% CI −0.19 to −0.04); P = 0.007

As reported in the abstract

Further pooled results

OutcomeDifference (mg/dL) (95% CI)P value
FPG changeComparable−3.37 (−7.95 to 1.21)P = 0.14
OutcomeDifference (% of total time) (95% CI)P value
TIR+2.41 (1.13–3.69)P = 0.002

Effect consistency (meta-regression)

Consistent effect sizes across OW insulin types, treatment durations and prior insulin regimens

Safety

Body weight change

Modest weight gain excluding trials using IcoSema
+0.33 kg (95% CI 0.04 to 0.62, p = 0.030)
Body weight changes generally similar

Clinically significant or severe hypoglycaemia

Incidence did not differ between groups; pooled IRR
1.04 (95% CI 0.79 to 1.28, p = 0.75)

Original publication

Efficacy and safety of once‐weekly insulins in type 2 diabetes: A systematic review and meta‐analysis. Diabetes Obes Metab. Published 23 January 2026. doi:10.1111/dom.70497

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.